ACWA Power’s Bokpoort Concentrated Solar Power Plant Breaks African Record

ACWA Power’s Bokpoort Concentrated Solar Power Plant Breaks African Record
TT

ACWA Power’s Bokpoort Concentrated Solar Power Plant Breaks African Record

ACWA Power’s Bokpoort Concentrated Solar Power Plant Breaks African Record

ACWA Power, a leading developer, investor and operator of power generation and desalinated water plants worldwide, announced Wednesday that its South African Bokpoort CSP plant has become the first renewable facility in the continent to complete a full week of continuous round the clock operation.

Bokpoort CSP set the new African continental benchmark achieving 13 days (312 hours) of continuous operations on Oct. 23, 2020, which translates to approximately 13GWh of energy supply to the grid at an energy load factor of 83%, and 20 hours of full load operations daily (with a 50MW turbine) akin to base-load technologies — almost double the previous record it had set in March 2016.

This accomplishment was made possible by optimally managing 9.3 hours of the thermal salt storage system overnight, which allowed for a perfectly timed transition to the solar field every morning for the entire duration of this effort.

The plant delivered the highest ever production for the months of August and September and has continued to deliver an excellent performance in October 2020, achieving an all-time highest daily record of 1,028MWh earlier this month, despite global challenges and lockdown protocol arising from the COVID19 pandemic.

The 50 MW concentrated solar power (CSP) plant with thermal storage was commissioned during the 2nd bidding window of South Africa’s Renewable Energy Independent Power Producer Program (REIPPP) and has been setting consistent records, since commencement of its commercial operations in 2016.



UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
TT

UAE’s Mubadala Acquires Majority Stakes in Global Medical Supply Chain, Al Ittihad Drug

The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM
The acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors. WAM

Mubadala Investment Company has acquired an 80% stake in Global Medical Supply Chain (GMSC) and Al Ittihad Drug Store (IDS) from GlobalOne Healthcare Holding (GHH), with GHH retaining a 20% stake, Emirates News Agency (WAM) reported on Tuesday.

This strategic acquisition enhances Mubadala's footprint in the healthcare logistics and pharmaceutical distribution sectors, aligning with the UAE's vision to establish a robust life sciences infrastructure, WAM said.

Founded in 2015, GMSC provides comprehensive end-to-end supply chain services for medical products, including demand planning, procurement, logistics, inventory management, warehousing, and maintenance.

GMSC serves over 200 medical facilities, including hospitals and clinics across the UAE. With a dedicated team of medical supply chain specialists, GMSC sources a broad array of products from almost 400 suppliers, ensuring a reliable supply chain for all medical needs.

IDS, established in 1987, stands as one of the leading distributors of pharmaceutical and consumer healthcare products in the UAE. Distributing over 1,000 products from over 40 leading suppliers, IDS services every hospital, and all, or at least most pharmacies and supermarkets within the UAE. It boasts a vast portfolio that spans multiple therapeutic categories including anti-infectives, asthma, diabetes, and oncology.

"The expanding pharmaceutical market drives an increasing demand for specialized and efficient drug logistics solutions. By integrating GMSC and IDS into our portfolio, we are poised to create a vertically integrated life sciences sector in the UAE and enable its potential to encompass the entire value chain from logistics and distribution to specialized manufacturing,” said Executive Director of UAE Clusters at Mubadala's UAE Investments Platform Ismail Ali Abdulla.

As for Low Ping, Group CEO Yas Holding, she said that the transaction “continues Mubadala's strategic growth, following another significant acquisition by its new speciality pharmaceutical business, KELIX bio, which recently acquired a 100% stake in four pharma assets from GlobalOne Healthcare Holding's, the healthcare division of Yas Holding.”

“These concerted efforts underline Mubadala's commitment to strengthening the UAE's healthcare and pharmaceutical sectors as part of broader national ambitions for drug security and economic diversification."

GlobalOne Healthcare Holding LLC serves as the dedicated Healthcare Division of Yas Holding LLC, focusing on enhancing healthcare outcomes by investing in innovative solutions across various healthcare verticals.